Cytomos
Latest round
- Seed
Last raised
- Jun 2022
Total raised
- $2.1M
Investors
- 3
About Cytomos
Based in Edinburgh, UK, and founded in 2012 by its CEO Keith Muir, Cytomos Limited operates as a life science company that develops technology platforms for analyzing cells. Cytomos Limited offers Cytomos Dielectric Spectroscopy (CDS), a full-stack, single-cell resolution analysis technology, spanning integrated sensors through to machine learning-enhanced algorithms. It applies an electric field across single cells in suspension, measuring more than 16,000 frequencies per cell. The company's platform enables quantitative and qualitative cytometry without the requirement for cell labelling reagents.
Who invested in Cytomos
3 investors across 1 round
See all investors in Cytomos
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Jun 16, 2022
Amount
$2.1M
Investors
Questions about Cytomos
Who invested in Cytomos?
Cytomos has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Cytomos raised?
Cytomos has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Cytomos last raise money?
Cytomos's most recent round on record is a Seed, in Jun 2022.
What does Cytomos do?
Based in Edinburgh, UK, and founded in 2012 by its CEO Keith Muir, Cytomos Limited operates as a life science company that develops technology platforms for analyzing cells.
Where is Cytomos headquartered?
Cytomos is headquartered in Edinburgh, UK.
Which VCs invest in companies like Cytomos?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back biotechnology companies at Cytomos's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Cytomos? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.